|Bid||0.00 x 1000|
|Ask||0.00 x 1000|
|Day's range||615.68 - 627.80|
|52-week range||441.00 - 686.62|
|Beta (5Y monthly)||0.17|
|PE ratio (TTM)||9.89|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Regeneron (REGN), Vertex Pharmaceuticals (VRTX) and BioNTech (BNTX) are three large biotech stocks that are worth betting on in the current scenario.
CommScope (COMM), Microchip (MCHP), Regeneron (REGN), Bunge (BG) and Hologic (HOLX) are some of the stocks with high ROE to profit as Q4 earnings witness shaky start to the season.
After a series of delays, Pfizer's (PFE) oral JAK inhibitor, Cibinqo (abrocitinib), gets approval for treating adults with atopic dermatitis in the United States.